Safety of shorter ocrelizumab infusion confirmed over multiple administrations: results of the ENSEMBLE PLUS substudy

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2022
This article has no abstract
Epistemonikos ID: 2a489482cddb40e34cd5da91fe35171fbd083cfe
First added on: Apr 30, 2026